Ayse Batova, Ph.D.; Member, Board of Directors
Dr. Ayse Batova has 22 years of research experience in molecular cancer therapeutics. She is currently Faculty at the University of California, San Diego in the Department of Chemistry where she is investigating the mechanism of action of immunomodulators and chemotherapeutics targeting tumor metabolism. Dr. Batova is an inventor on a patent covering the synthesis and use of a gambogic acid analog as a therapeutic agent. For 15 years Dr. Batova was Faculty in the Department of Pediatrics (Hematology/Oncology) at UCSD where she investigated the molecular basis of T-cell Acute Lymphoblastic Leukemia and Neuroblastoma. She has been instrumental in Phase 2 and Phase 3 clinical trials of an anti-GD2 monoclonal antibody for refractory Neuroblastoma. Additionally, she worked on Integrin biology at Telios Pharmaceuticals and has extensive experience with the mechanisms of growth control and differentiation of retinoids in normal and transformed epithelial cells. Dr. Batova received her PhD in Biochemistry/Chemistry at the University of Southern Carolina and a B.A. in Chemistry at the college of Wooster.